lobbying_activities: 2713705

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2713705	5ff74072-4c47-4a86-8122-ae78a22c0973	Q3	PURDUE PHARMA, LP	81214	PURDUE PHARMA LP	2021	third_quarter	BNK	Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.	HOUSE OF REPRESENTATIVES,SENATE		118375	0	0	2021-10-20T21:24:47.787000-04:00